ArticleOncogene2002

MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.

Natasha Atanaskova et al.PubMed ↗Publisher ↗

No numbers read from the abstract.